Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands
CJM de Blok, CM Wiepjes, NM Nota, K van Engelen… - Bmj, 2019 - bmj.com
Objective To investigate the incidence and characteristics of breast cancer in transgender
people in the Netherlands compared with the general Dutch population. Design …
people in the Netherlands compared with the general Dutch population. Design …
[HTML][HTML] An Update on the General Features of Breast Cancer in Male Patients—A Literature Review
Male breast cancers are uncommon, as men account for less than 1 percent of all breast
carcinomas. Among the predisposing risk factors for male breast cancer, the following …
carcinomas. Among the predisposing risk factors for male breast cancer, the following …
[HTML][HTML] Biological Basis of Breast Cancer-Related Disparities in Precision Oncology Era
Precision oncology is based on deep knowledge of the molecular profile of tumors, allowing
for more accurate and personalized therapy for specific groups of patients who are different …
for more accurate and personalized therapy for specific groups of patients who are different …
[HTML][HTML] Cytoplasmic DDX3 as prognosticator in male breast cancer
CC van der Pol, CB Moelans, QF Manson… - Virchows Archiv, 2021 - Springer
Male breast cancer (MBC) is a rare disease. Due to its rarity, treatment is still directed by
data mainly extrapolated from female breast cancer (FBC) treatment, despite the fact that it …
data mainly extrapolated from female breast cancer (FBC) treatment, despite the fact that it …
[HTML][HTML] PD-1 and PD-L1 expression in male breast cancer in comparison with female breast cancer
QF Manson, ND Ter Hoeve, H Buerger, CB Moelans… - Targeted Oncology, 2018 - Springer
Background Male breast cancer is rare, as it represents less than 1% of all breast cancer
cases. In addition, male breast cancer appears to have a different biology than female breast …
cases. In addition, male breast cancer appears to have a different biology than female breast …
[HTML][HTML] Marital status and survival of patients with hormone receptor-positive male breast cancer: a surveillance, epidemiology, and end results (SEER) population …
L Liu, YY Chi, AA Wang, Y Luo - Medical science monitor …, 2018 - ncbi.nlm.nih.gov
Background Although marital status has been reported as a prognostic factor in different
cancer types, its prognostic effect on hormone receptor (HR) positive male breast cancer …
cancer types, its prognostic effect on hormone receptor (HR) positive male breast cancer …
[HTML][HTML] Case report: male lobular breast cancer in hereditary cancer syndromes
I Carnevali, G Tedaldi, V Pensotti, N Sahnane… - Frontiers in …, 2022 - frontiersin.org
Background Lobular breast carcinoma (LBC) is considered an exceptionally rare disease in
men, including only 1% of all male breast malignancies. The majority of LBCs have negative …
men, including only 1% of all male breast malignancies. The majority of LBCs have negative …
Androgen receptor expression inversely correlates with histological grade and N stage in ER+/PgRlow male breast cancer
Abstract Purpose Androgen Receptor (AR) positivity is often displayed in breast cancer and
especially in Male Breast Cancer (MBC), where it appears to be a heterogeneous feature …
especially in Male Breast Cancer (MBC), where it appears to be a heterogeneous feature …
Utility of Oncotype DX in male breast cancer patients and impact on chemotherapy administration: a comparative study with female patients
AD Williams, CM McGreevy, JC Tchou… - Annals of Surgical …, 2020 - Springer
Abstract Background Use of the Oncotype DX recurrence score (RS) has been widely
adopted in women with early-stage hormone receptor-positive (HR+), human epidermal …
adopted in women with early-stage hormone receptor-positive (HR+), human epidermal …
Gender differences in recommended treatment decisions among breast Cancer patients: a study using the National Cancer Database
Background Previous studies have explored surgery refusal among female breast cancer
patients. However, little attention has been given to other therapies in both females and …
patients. However, little attention has been given to other therapies in both females and …